Authors: You, JHS Lee, KKC Ho, SSS Sung, JJY Kung, NNS Yung, M Lee, C Yee, GC

Citation: Jhs. You et al., Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong, ALIM PHARM, 15(7), 2001, pp. 1009-1015

Authors: Wong, BCY Wang, WH Wong, WM Lau, GKK Fung, FMY Kung, NNS Chu, KM Lai, KC Hu, WHC Hu, FL Liu, XG Chan, CK Yuen, MF Hui, WM Lam, SK

Citation: Bcy. Wong et al., Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study, ALIM PHARM, 15(6), 2001, pp. 843-849

Authors: Sung, JJY Lao, WC Lai, MS Li, TH Chan, FKL Wu, JCY Leung, VKS Luk, YW Kung, NNS Ching, JYL Leung, WK Lau, J Chung, SJY

Citation: Jjy. Sung et al., Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies, GASTROIN EN, 54(4), 2001, pp. 454-458

Authors: Ma, SK Chow, EYD Chan, AYY Kung, NNS Waye, JS Chan, LC Chui, DHK

Citation: Sk. Ma et al., beta-thalassemia intermedia caused by compound heterozygosity for Hb Malay(beta codon 19 AAC -> AGC; Asn -> Ser) and codons 41/42 (-CTTT) beta(0)-thalassemia mutation, AM J HEMAT, 64(3), 2000, pp. 206-209

Authors: Kung, NNS Sung, JJY Yuen, NWF Li, TH Ng, PW Lai, WM Lui, YH Lam, KN Choi, CH Leung, MF

Citation: Nns. Kung et al., One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: A prospective randomized controlled trial, AM J GASTRO, 94(3), 1999, pp. 721-724